Prognia
Drug Database
🇺🇸US · FDA ApprovedDiscontinuedNDA022510-005

ABSTRAL(FENTANYL CITRATE)

Manufacturer: SENTYNL THERAPS INC

FDA Approval: 07/01/2011

Route: SUBLINGUAL · TABLET

Active Ingredients

FENTANYL CITRATE EQ 0.6MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about ABSTRAL — check interactions with your patient's full medication list, get dosing recommendations with renal/hepatic adjustments, and explore guideline-cited evidence.

Medical disclaimer: This drug information is intended for qualified healthcare professionals only. Always verify with the official FDA prescribing information before clinical use.